Mesothelin mRNA has previously been described as overexpressed in ovarian and mesothelioma cancer tissues, and the gene product is referred to a marker of these two cancers (Ordonez, 2003; Drapkin et al, 2004; McIntosh et al, 2004). Here, MSLN is linked to cancer.